Insider Transactions last 24 months for Ligand Pharmaceuticals Incorporated  -  NSDQ: LGND

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Reardon AndrewCLO & Secretary04/01/2026DSDirectCOM337$204.50$68,917.3841,382
Reardon AndrewCLO & Secretary04/01/2026DSDirectCOM963$203.22$195,702.5941,719
Reardon AndrewCLO & Secretary04/01/2026DSDirectCOM700$201.90$141,327.9742,682
Reardon AndrewCLO & Secretary04/01/2026DSDirectCOM1,238$200.94$248,767.3143,382
Reardon AndrewCLO & Secretary04/01/2026DSDirectCOM1,302$199.72$260,038.1744,620
Reardon AndrewCLO & Secretary04/01/2026DSDirectCOM460$198.85$91,470.6845,922
Reardon AndrewCLO & Secretary04/01/2026AMDirectCOM5,000$52.27$261,350.0046,382
Kozarich John WDirector04/01/2026DSDirectCOM159$204.26$32,477.7742,253
Kozarich John WDirector04/01/2026DSDirectCOM43$202.91$8,725.2242,412
Kozarich John WDirector04/01/2026DSDirectCOM79$202.42$15,991.3642,455
Kozarich John WDirector04/01/2026DSDirectCOM40$201.24$8,049.4042,534
Kozarich John WDirector04/01/2026DSDirectCOM146$199.97$29,196.3442,574
Sabba Stephen LDirector03/23/2026DSDirectCOM1,000$207.87$207,872.7032,793
Espinoza OctavioChief Financial Officer03/11/2026DSDirectCOM3,057$225.00$687,825.0021,010
Espinoza OctavioChief Financial Officer03/11/2026AMDirectCOM2,405$92.65$222,823.2524,067
Lamattina John LDirector03/06/2026DSDirectCOM2,161$200.76$433,842.3630,724
Lamattina John LDirector03/06/2026AMDirectCOM2,161$114.15$246,678.1532,885
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM3,413$208.80$712,620.7521,662
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM2,457$207.91$510,823.0825,075
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM1,588$206.89$328,541.9627,532
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM1,457$205.79$299,841.4229,120
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM743$204.74$152,125.4630,577
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM668$203.63$136,023.9731,320
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM697$202.79$141,342.7531,988
Espinoza OctavioChief Financial Officer03/04/2026DSDirectCOM950$201.73$191,640.2732,685
1   2  3  4  5  6  7  8  9  10  Next Last  You are at page 1 of 10 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust
Export Table Data to Excel Send to Excel